| Andrea Neolus Bailey, MD | |
|
1310 Southern Ave Se, Great Southeast Community Hospital, Washington, DC 20032 | |
| (202) 574-6000 | |
| Not Available |
| Full Name | Andrea Neolus Bailey |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 1310 Southern Ave Se, Washington, District Of Columbia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184897761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD33452 (District Of Columbia) | Primary |
| 208000000X | Pediatrics | R0044694 (Maryland) | Secondary |
| 208000000X | Pediatrics | G84272 (California) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrea Neolus Bailey, MD 5425 14th St Nw, Childrens Medical Care Center, Washington, DC 20011 Ph: (202) 829-7700 | Andrea Neolus Bailey, MD 1310 Southern Ave Se, Great Southeast Community Hospital, Washington, DC 20032 Ph: (202) 574-6000 |
News Archive
Eli Lilly and Company has accepted the recommendation of the ACCELERATE study academic executive committee, based on emerging science in the cardiovascular field, to extend the Phase 3 trial of the investigational medicine evacetrapib by approximately six months.
Researchers have found new evidence linking losses in memory and attention to subtle forms of brain damage following mild traumatic brain injury (TBI), which may eventually help in diagnosing when a routine concussion might lead to lasting cognitive problems.
Avid Radiopharmaceuticals, Inc. today announced the presentation of interim data from its landmark florbetapir "Image-to-Autopsy" Phase III study. These data come from the first cohort of subjects in the trial and are the first ever Phase III results for an agent designed to image Alzheimer's disease pathology.
Researchers at UT Southwestern Medical Center hope they have begun paving a new pathway in the fight against drug dependence. Their hypothesis - that increasing the normally occurring process of making nerve cells might prevent addiction - is based on a rodent study demonstrating that blocking new growth of specific brain nerve cells increases vulnerability for cocaine addiction and relapse.
Just as other industries are rolling back some consumer-friendly changes made early in the pandemic — think empty middle seats on airplanes — so, too, are health insurers.
› Verified 1 days ago
Dr. Talita Michelle Jordan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Yue-hin Loke, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, W3.5, 600, Washington, DC 20010 Phone: 202-476-3670 | |
Elshadey Yayehyerade Bekele, Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 301-565-4279 | |
Jia Liu, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Dr. Charles John Billington Jr., MDPHD Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, W3.5, 600, Washington, DC 20010 Phone: 202-476-3670 Fax: 202-476-4741 | |
Dr. Joy Marie Morgan, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Nicole V Lang, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1145 19th St Nw, Ste 708, Washington, DC 20036 Phone: 202-955-5625 Fax: 202-955-5626 |